Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Biomedicines|August 28, 2025
Gene Therapy of Adrenomyeloneuropathy: Challenges, Target Cells, and ProspectivesPierre Bougnères, Catherine Le Stunff, Romina Aron Badin
Human Gene Therapy|December 26, 2024
Intracisternal AAV9-MAG-hABCD1 Vector Reverses Motor Deficits in Adult Adrenomyeloneuropathy MiceYasemin Özgür Günes, Catherine Le Stunff, Pierre Bougnères
Diabetes|December 12, 2002
Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphismsSophie Le Fur, Catherine Le Stunff, Pierre Bougnères
Cells|December 17, 2024
Oligodendrocytes, the Forgotten Target of Gene TherapyYasemin Ozgür-Gunes, Catherine Le Stunff, Pierre Bougnères
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
A homozygous null mutation delineates the role of the melanocortin-4 receptor in humansCécile Lubrano-Berthelier, Catherine Le Stunff, Pierre Bougnères, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2008
Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhoodPierre Bougnères, Letitia Pantalone, Agnès Linglart, et al.
Physiological Genomics|December 6, 2003
INS VNTR is a QTL for the insulin response to oral glucose in obese childrenChristine Dos Santos, Daniele Fallin, Catherine Le Stunff, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 2007
A single-nucleotide polymorphism in the p110beta gene promoter is associated with partial protection from insulin resistance in severely obese adolescentsCatherine Le Stunff, Agnès Dechartres, Emanuele Miraglia Del Giudice, et al.
Pageof 3